Back
Compass Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
48
CMPX
Compass Therapeutics, Inc.
Last Price:
$5.44
Seasonality Move:
9.93%
7 Day Trial
ALL ACCESS PASS
$
7
Compass Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Compass Therapeutics, Inc. has on average historically risen by 66.6% based on the past 4 years of stock performance.
-
Compass Therapeutics, Inc. has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
-
Is Compass Therapeutics, Inc. Stock Undervalued?The current Compass Therapeutics, Inc. [CMPX] share price is $5.45. The Score for CMPX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
CMPX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Compass Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Compass Therapeutics, Inc. has on average historically risen by 66.6% based on the past 4 years of stock performance.
Compass Therapeutics, Inc. Stock Rating
Sell
48
Compass Therapeutics, Inc. (CMPX)
is a Sell
Is Compass Therapeutics, Inc. overpriced?
-
Compass Therapeutics, Inc. has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
Compass Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
compasstherapeutics.com
52-Week Data
52-Week High:
6.88
52-Week Low:
1.40
Prediction Charts
Market Cap:
983.3M
Price in USD:
5.45
Volume:
3.2M
Beta:
1.30
Technical Analysis
SMA50:
5.84
SMA100:
5.51
SMA200:
4.42
52-Wk Change:
222.49%
Stock Predictions
-
Is Compass Therapeutics, Inc. stock public?Yes, Compass Therapeutics, Inc. is a publicly traded company.
-
What is the Compass Therapeutics, Inc. stock quote today?The Compass Therapeutics, Inc. stock price is 5.45 USD today.
-
How to buy Compass Therapeutics, Inc. stock online?You can buy Compass Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-16 | 5.24 | 5.41 | 5.53 | 5.20 |
| Mar-17 | 5.39 | 5.45 | 5.54 | 5.31 |
| Mar-18 | 5.41 | 5.32 | 5.41 | 5.23 |
| Mar-19 | 5.27 | 5.39 | 5.40 | 5.19 |
| Mar-20 | 5.40 | 5.15 | 5.44 | 5.14 |
| Mar-23 | 5.16 | 5.04 | 5.29 | 5.00 |
| Mar-24 | 4.96 | 5.33 | 5.39 | 4.87 |
| Mar-25 | 5.42 | 5.49 | 5.56 | 5.39 |
| Mar-26 | 5.41 | 5.33 | 5.67 | 5.30 |
| Mar-27 | 5.29 | 5.21 | 5.37 | 5.15 |
| Mar-30 | 5.21 | 5.10 | 5.24 | 5.07 |
| Mar-31 | 5.26 | 5.29 | 5.38 | 5.06 |
| Apr-1 | 5.41 | 5.43 | 5.51 | 5.11 |
| Apr-2 | 5.25 | 5.45 | 5.50 | 5.18 |
Compass Therapeutics, Inc. Earnings
Compass Therapeutics, Inc. Earnings Report: Per Share Compass Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Compass Therapeutics, Inc. Forecast Revenue Growth
Compass Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Compass Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.01 per share, and a decrease next year of $0.07 per share.
* Compass Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.